Clinical presentation and management of maturity-onset diabetes of the young (MODY12)

Nguyen Hoang Lan, Can Thi Bich Ngoc

Main Article Content

Abstract

Maturity-Onset Diabetes of the Young (MODY) is a monogenic form of diabetes caused by beta-cell dysfunction, inherited in an autosomal dominant pattern. Fourteen MODY subtypes (MODY1–14) have been identified, each with distinct clinical features and management strategies. We report a case of MODY12 due to a heterozygous pathogenic variant c.3544C>T (p.Arg1182Trp) in the ABCC8 gene, which encodes the SUR1 subunit of the pancreatic K_ATP channel. A 14-year-old boy was admitted with polyuria, polydipsia, and weight loss. Laboratory tests showed fasting plasma glucose of 14.6 mmol/L, HbA1c of 14.2%, C-peptide 1.04 ng/mL, insulin 3.75 mU/L, and positive urine ketones (++). His mother was diagnosed with type 1 diabetes at age 15, and his maternal grandmother had diabetes diagnosed at age 60, currently treated with insulin. Following genetic confirmation of the ABCC8 variant, insulin therapy was successfully switched to oral sulfonylurea within three days. This case highlights the importance of genetic testing for MODY in individuals with a multi-generational family history of diabetes and clinical features atypical for either type 1 or type 2 diabetes, enabling optimized treatment and avoidance of unnecessary insulin therapy.

Article Details

References

1. American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. 2024; 47(Suppl 1): S20-S42. doi:10.2337/dc24-S002.
2. Kim SH. Maturity-Onset Diabetes of the Young: What Do Clinicians Need to Know? Diabetes Metab J. 2015; 39(6): 468-477. doi:10.4093/dmj.2015.39.6.468.
3. Anık A, Çatlı G, Abacı A, Böber E. Maturity-onset diabetes of the young (MODY): an update. J Pediatr Endocrinol Metab. 2015; 28(3-4): 251-263. doi:10.1515/jpem-2014-0384
4. Timmers M, Dirinck E, Lauwers P, Wuyts W, De Block C. ABCC8 variants in MODY12: Review of the literature and report of a case with severe complications. Diabetes Metab Res Rev. 2021; 37(8): e3459. doi:10.1002/dmrr.3459.
5. Li M, Gong S, Han X, et al. Genetic variants of and phenotypic features in Chinese early onset diabetes. Journal of Diabetes. 2021; 13(7): 542-553. doi:10.1111/1753-0407.13144.
6. Riveline JP, Rousseau E, Reznik Y, et al. Clinical and Metabolic Features of Adult-Onset Diabetes Caused by ABCC8 Mutations. Diabetes Care. 2012; 35(2): 248-251. doi:10.2337/dc11-1469.
7. Libman I, Haynes A, Lyons S, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2022; 23(8): 1160-1174. doi:10.1111/pedi.13454.
8. Tang C, Meng L, Zhang P, et al. Case Report: A Novel ABCC8 Variant in a Chinese Pedigree of Maturity-Onset Diabetes of the Young. Front Endocrinol (Lausanne). 2021; 12: 758723. doi:10.3389/fendo.2021.758723.
9. Urbanová J, Rypáčková B, Procházková Z, et al. Positivity for islet cell autoantibodies in patients with monogenic diabetes is associated with later diabetes onset and higher HbA1c level. Diabet Med. 2014; 31(4): 466-471. doi:10.1111/dme.12314.
10. Kapoor RR, James C, Hussain K. Advances in the diagnosis and management of hyperinsulinemic hypoglycemia. Nat Clin Pract Endocrinol Metab. 2009; 5(2): 101-112. doi:10.1038/ncpendmet1046.
11. Kapoor RR, Flanagan SE, James C, Shield J, Ellard S, Hussain K. Hyperinsulinaemic hypoglycaemia. Arch Dis Child. 2009; 94(6): 450-457. doi:10.1136/adc.2008.148171.
12. Case report: Maturity-Onset Diabetes of the Young (MODY12) caused by ABCC8 gene mutations | International Journal of Diabetes in Developing Countries. Accessed April 6, 2025. https://link.springer.com/article/10.1007/s13410-023-01179-3.
13. Rafiq M, Flanagan SE, Patch AM, et al. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care. 2008; 31(2): 204-209. doi:10.2337/dc07-1785.
14. Nakhleh A, Goldenberg-Furmanov M, Goldstein R, Shohat M, Shehadeh N. A beneficial role of GLP-1 receptor agonist therapy in ABCC8-MODY (MODY 12). J Diabetes Complications. 2023; 37(9): 108566. doi:10.1016/j.jdiacomp.2023.108566.